Cohort description and study design. (A) PFS at 1 year of the prospectively collected 50-patient cohort. Bar graph of response at 12 months for this cohort (inset). (B) Forest plot of patient characteristics. P values (Fisher test) and LASSO coefficients shown comparing Rs vs NRs. (C) Schematic of the cohorts and sample collection of this study. Dark circles represent PBMCs; open square, infusion products (IPs); and open triangle, clinical complete blood count (CBC) with differential. ASCT, autologous stem cell transplant; CRS, cytokine release syndrome; DLBCL, diffuse LBCL; Flu/Cy, fludarabine and cyclophosphamide; GCB, germinal center B-cell–like; ICANS, immune effector cell–associated neurotoxicity syndrome; LDH, lactate dehydrogenase; PET/CT, positron emission tomography–computed tomography; ULN, upper limit of normal.